Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Nicoli

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Non-Coding RNA|August 27, 2025
circRNA/miRNA Networks Regulate KLF4 in Tumor DevelopmentRaffaele Frazzi, Enrico Farnetti, Davide Nicoli
The Journal of Clinical Endocrinology and Metabolism|June 29, 2012
BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomasValentina Sancisi, Davide Nicoli, Moira Ragazzi, et al.
International Journal of Oncology|January 18, 2011
Increase in clusterin forms part of the stress response in Hodgkin's lymphomaRaffaele Frazzi, Bruno Casali, Mauro Iori, et al.
Endocrine Pathology|January 20, 2016
Critical Pitfalls in the use of BRAF Mutation as a Diagnostic Tool in Thyroid Nodules: a Case ReportElisabetta Kuhn, Moira Ragazzi, Michele Zini, et al.
Journal of Child Neurology|March 2, 2012
Very early onset and severe complicated phenotype caused by a new spastic paraplegia 3A gene mutationCarlo Fusco, Daniele Frattini, Enrico Farnetti, et al.
Plos One|September 27, 2013
Cadherin 6 is a new RUNX2 target in TGF-β signalling pathwayValentina Sancisi, Greta Gandolfi, Moira Ragazzi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2017
Peptide Receptor Radionuclide Therapy-Induced Gitelman-like SyndromeAurelio Negro, Giovanni M Rossi, Davide Nicoli, et al.
The Journal of Clinical Endocrinology and Metabolism|July 24, 2012
Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomasValentina Sancisi, Gloria Borettini, Sally Maramotti, et al.
Brain & Development|September 9, 2009
Hereditary spastic paraplegia and axonal motor neuropathy caused by a novel SPG3A de novo mutationCarlo Fusco, Daniele Frattini, Enrico Farnetti, et al.
Internal and Emergency Medicine|April 16, 2013
Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: the need for further revision of dose and scheduleElena Magnani, Enrico Farnetti, Davide Nicoli, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Non-Coding RNA|August 27, 2025
circRNA/miRNA Networks Regulate KLF4 in Tumor DevelopmentRaffaele Frazzi, Enrico Farnetti, Davide Nicoli
The Journal of Clinical Endocrinology and Metabolism|June 29, 2012
BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomasValentina Sancisi, Davide Nicoli, Moira Ragazzi, et al.
International Journal of Oncology|January 18, 2011
Increase in clusterin forms part of the stress response in Hodgkin's lymphomaRaffaele Frazzi, Bruno Casali, Mauro Iori, et al.
Endocrine Pathology|January 20, 2016
Critical Pitfalls in the use of BRAF Mutation as a Diagnostic Tool in Thyroid Nodules: a Case ReportElisabetta Kuhn, Moira Ragazzi, Michele Zini, et al.
Journal of Child Neurology|March 2, 2012
Very early onset and severe complicated phenotype caused by a new spastic paraplegia 3A gene mutationCarlo Fusco, Daniele Frattini, Enrico Farnetti, et al.
Plos One|September 27, 2013
Cadherin 6 is a new RUNX2 target in TGF-β signalling pathwayValentina Sancisi, Greta Gandolfi, Moira Ragazzi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2017
Peptide Receptor Radionuclide Therapy-Induced Gitelman-like SyndromeAurelio Negro, Giovanni M Rossi, Davide Nicoli, et al.
The Journal of Clinical Endocrinology and Metabolism|July 24, 2012
Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomasValentina Sancisi, Gloria Borettini, Sally Maramotti, et al.
Brain & Development|September 9, 2009
Hereditary spastic paraplegia and axonal motor neuropathy caused by a novel SPG3A de novo mutationCarlo Fusco, Daniele Frattini, Enrico Farnetti, et al.
Internal and Emergency Medicine|April 16, 2013
Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: the need for further revision of dose and scheduleElena Magnani, Enrico Farnetti, Davide Nicoli, et al.
Pageof 7